Understanding the long-term effects of treatment in Hodgkin lymphoma patients
Official title: Modeling Multi-Source Data in Hodgkin Lymphoma
Funded at Tufts Medical Center · NIH-11046511 · Data updated 2026-11-12
This study is looking at how treatments for Hodgkin lymphoma might affect your health in the long run, especially regarding risks for other cancers and heart problems, using information from over 12,000 patients to help understand these effects better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tufts Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | March 1, 2022 |
| Project end | February 28, 2027 |
| Funding year | 2025 |
| Award (this year) | $600,045 |
| NIH project number | 5R01CA262265-04 |
| Project ID | NIH-11046511 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals aged 21 and older who have been treated for Hodgkin lymphoma and are currently undergoing active follow-up care.
✕Less likely to help
Patients who have not received treatment for Hodgkin lymphoma or those who are not in the active follow-up phase may not benefit from this research.
What this research studies
This research investigates the long-term health impacts of Hodgkin lymphoma treatments, focusing on late effects such as secondary cancers and cardiovascular diseases. By utilizing data from over 12,000 patients across multiple clinical trials and registries, the study aims to create a comprehensive model that links treatment outcomes with patient health over time. The approach involves collaboration among experts in oncology, epidemiology, and data science to analyze and harmonize patient data for better insights into post-treatment morbidity and survival.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies that minimize long-term health risks for Hodgkin lymphoma survivors.
How similar studies have gone: Previous research has successfully utilized similar data modeling approaches to understand long-term outcomes in cancer patients, indicating a promising potential for this study.
Where this research is happening
-
Tufts Medical Center
Boston, United States Active
Researchers
- Principal investigator: Parsons, Susan Kenyon — Tufts Medical Center
- Study coordinator: Parsons, Susan Kenyon
Related research
Other NIH-funded projects on the same topics.
-
Understanding why Black and Hispanic Hodgkin lymphoma patients have worse survival
A patient-centered study to uncover social and care factors that contribute to lower survival among Black and Hispanic people with Hodgkin lymphoma across all ages.
-
Novel combination therapy for non-Hodgkin lymphoma in people and dogs
A new treatment combo using an oncolytic virus and other therapies is being tested to help people with hard-to-treat non-Hodgkin lymphoma, with studies also involving dogs to better understand responses.
-
Trajectories of Neurotoxicity in young Hodgkin lymphoma patients
Aging Hodgkin lymphoma patients who are adolescents or young adults may face long-lasting brain and nerve-related side effects from their cancer treatment, and this study aims to map how those problems develop over time.
-
Combination therapy approach for non-Hodgkin lymphoma (NHL)
A Mayo Clinic team is testing a new combination treatment for non-Hodgkin lymphoma to improve responses in patients and in dogs with similar disease.
-
Multi-antigen T cell therapy for relapsed NHL
A patient-derived T cell therapy called MT-601 targets six tumor-associated antigens to help treat relapsed non-Hodgkin lymphoma after other therapies may have failed.
-
Personalized de‑intensification of therapy for NLP Hodgkin lymphoma
A clinician-scientist at Stanford is developing a patient-centered program to tailor and reduce therapy for nodular lymphocyte-predominant Hodgkin lymphoma using tumor and blood samples.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.